The environment strongly influences health outcomes, especially in industrialized societies. A new study from the Columbia University Mailman School of Public Health challenges the long-standing view that inflammation is a universal feature of aging. The research indicates that “inflammaging”—a p
Potential treatments for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases may already be out there in the form of drugs prescribed for other conditions. A team of researchers from Lawrence Livermore National Laboratory (LLNL), Stanford University and the University of California, Los Angeles (UCLA) are using artificial intelligence and machine learning (AI/ML) to try to find them.
Clinical trials for new drugs can take up to 5–7 years, so repurposing existing drugs is one of the best ways to deliver treatments quickly. AI/ML can make it even faster. By analyzing long-term electronic health records (EHRs) of patients with ALS, the team can identify drugs — or combinations of drugs — prescribed for other conditions that may influence the progression of the disease. The drugs’ “off-target” effects may not only affect patient survival but also provide insight into how neurodegenerative diseases work and inform better therapies.
“If you talk to any ALS caregiver, you will be moved because the disease has such a grim prognosis, so being able to do something is tremendously motivating,” said Priyadip Ray, a staff scientist in LLNL’s Computational Engineering Division (CED) who leads the effort.
This review examines neoadjuvant chemotherapy for head and neck squamous cell carcinoma to address current literature, evolving research, and gaps in knowledge.
Tesla’s launch of a robo-taxi network marks the beginning of a significant transportation disruption that will transform mobility, economy, geopolitics, and urban landscapes with the widespread adoption of electric autonomous vehicles ## ## Questions to inspire discussion.
Transportation Revolution.
🚗 Q: How will Tesla’s Robotaxi network impact transportation? A: Tesla’s Robotaxi network in Austin, Texas marks the ignition point for transportation disruption, with multiple companies competing to provide taxi rides without human drivers, potentially capturing 80–90% market share in 10–15 years.
🛢️ Q: What industries will be disrupted by autonomous electric vehicles? A: Autonomous electric vehicles will disrupt the oil and agriculture industries, as vehicles are the number one users of crude oil, and corn is the top agricultural product in the US, used to produce ethanol for gasoline.
🌆 Q: How will urban planning change with the rise of autonomous vehicles? A: Cities will repurpose parking spaces for retail, living areas, and solar panels, transforming urban planning and enabling new forms of transportation, including drones and aircraft.
In a large-scale proteomic study of biological aging of 11 organs from 44,498 individuals in the UK Biobank, the biological ages of the brain and immune system emerged as strong predictors of healthspan and longevity.
The University of Sydney is a public research university located in Sydney, New South Wales, Australia. Founded in 1850, it is the oldest university in Australia and is consistently ranked among the top universities in the world. The University of Sydney has a strong focus on research and offers a wide range of undergraduate and postgraduate programs across a variety of disciplines, including arts, business, engineering, law, medicine, and science.
As waiting rooms fill up, doctors get increasingly burned out, and surgeries take longer to schedule and more get canceled, humanoid surgical robots offer a solution. That’s the argument that UC San Diego robotics expert Michael Yip makes in a perspective piece in Science Robotics.
Today’s surgical robots are costly pieces of equipment designed for specialized tasks and can only be operated by highly trained physicians. However, this model doesn’t scale.
Despite the drastic improvements in artificial intelligence and autonomy for industrial and humanoid robots in the past year, these improvements haven’t translated to surgical robots.
The world of wearable technology—such as sensors and energy-producing devices—is expanding, thanks to new research into a unique combination of materials that are flexible, safe to use on or inside the human body, and environmentally friendly.
Dr. Simon Rondeau-Gagné and a team of collaborators and graduate students have used the Canadian Light Source (CLS) at the University of Saskatchewan to show that semiconducting polymers and collagen—the main component of human skin—can be combined to create organic devices “that are more efficient, more conformable and specifically… more green as well.”
Collagen provided both the skin-like rigidity and elasticity (or bendability) the researchers were looking for in “a platform that can be integrated with something like the human body,” said Rondeau-Gagné, an associate professor in the Department of Chemistry and Biochemistry at the University of Windsor.
A traditionally overlooked type of RNA plays an important role in promoting resilience to depression—but only in females. According to a new study led by the Icahn School of Medicine at Mount Sinai, researchers have now discovered a novel role this molecule plays in how the female brain makes decisions. The authors revealed brain-region-specific and sex-dependent effects of this biomarker, translated from humans to animals, on how individuals make only certain types of choices. This study uncovered differences in how each sex decides whether to change their minds after making mistakes, including when to cut their losses and move on as well as how they process regrets about missed opportunities.
This research sheds important light on how specific types of decisions that could negatively impact mood engage the male and female brain in very different ways. The study, published July 11 in Science Advances, using laboratory animal models, helps uncover new biological and psychological mechanisms that may be linked to psychiatric vulnerabilities.
Women are twice as likely to develop depression than men. Furthermore, depression can manifest with different symptoms between the sexes, including alterations in negative rumination on the past. However, the neurobiological mechanisms underlying these differences remain unclear.